Global Pharmaceuticals & Biotech Most Popular Stocks

Arvinas

Market Cap: US$569.0m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Getein Biotech

Market Cap: CN¥4.1b

Researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally.

Guanhao BiotechLtd

Market Cap: CN¥4.0b

Develops, manufactures, and sells regenerative medicines and life sciences products primarily in China.

Jiangsu Hanbon Science and Technology

Market Cap: CN¥4.0b

Jiangsu Hanbon Science and Technology Co., Ltd.

Oruka Therapeutics

Market Cap: US$563.6m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Olema Pharmaceuticals

Market Cap: US$562.1m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

VISEN Pharmaceuticals

Market Cap: HK$4.4b

An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.

Medtide

Market Cap: HK$4.3b

A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.

Lionco Pharmaceutical GroupLtd

Market Cap: CN¥4.0b

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, research and development, production, sales and medical services in China.

Harbin Medisan Pharmaceutical

Market Cap: CN¥3.9b

Engages in the research, development, production, and sale of pharmaceutical product and medical devices in China.

Medicalsystem Biotechnology

Market Cap: CN¥3.9b

Engages in the research, development, production, and sales of in vitro diagnostic products in China.

Arcturus Therapeutics Holdings

Market Cap: US$551.5m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

Innova Captab

Market Cap: ₹48.4b

An integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs in India and internationally.

Shanghai Fudan Forward S&T

Market Cap: CN¥3.9b

Operates in software development, biomedicine, real estate, and other businesses.

COMPASS Pathways

Market Cap: US$543.0m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Eton Pharmaceuticals

Market Cap: US$540.1m

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Tuoxin Pharmaceutical GroupLtd

Market Cap: CN¥3.8b

Engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China.

Suven Life Sciences

Market Cap: ₹47.6b

A clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally.

Sequent Scientific

Market Cap: ₹47.6b

Operates in the veterinary healthcare business in Europe, Asia, and internationally.

Zevra Therapeutics

Market Cap: US$534.4m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Sichuan Goldstone Asia Pharmaceutical

Market Cap: CN¥3.8b

Sichuan Goldstone Asia Pharmaceutical Inc.

Shanghai Model Organisms Center

Market Cap: CN¥3.8b

Engages research and development, production, sale, and related technical services of genetically modified animal models.

Boji Medical TechnologyLtd

Market Cap: CN¥3.8b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Huaren Pharmaceutical

Market Cap: CN¥3.8b

Produces and sells non-PVC soft bag infusions in China.

Allergy Therapeutics

Market Cap: UK£395.6m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Personalis

Market Cap: US$530.3m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

Verastem

Market Cap: US$529.9m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Dong-A Socio Holdings

Market Cap: ₩745.9b

Engages in the pharmaceutical business in South Korea.

Bicycle Therapeutics

Market Cap: US$522.6m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

JCR Pharmaceuticals

Market Cap: JP¥78.1b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Antengene

Market Cap: HK$4.0b

A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

Esperion Therapeutics

Market Cap: US$516.2m

A pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States.

JS Link

Market Cap: ₩725.5b

A genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

Rigel Pharmaceuticals

Market Cap: US$514.8m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Erasca

Market Cap: US$513.4m

A clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Ever Supreme Bio Technology

Market Cap: NT$15.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.